Albumin plus diuretics for cirrhosis-related leg swelling
Treatments studied
Part of Digestive system, Kidney & urinary clinical trials.
This study tests whether giving albumin (a protein) along with water pills helps reduce leg swelling in people with cirrhosis and ascites. It may be an option if your leg swelling hasn't improved with standard diuretics alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (scarring of the liver) and currently or previously have had fluid buildup in your belly (ascites).
- You still have swelling in your legs even after taking water pills (diuretics) by mouth.
- Your blood albumin (a protein made by the liver) level is lower than 3.5 g/dL.
- You are 18 years old or older.
- You must not have severe kidney problems (GFR less than 30), recent infections in belly fluid, active bleeding from the esophagus, or certain heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests empagliflozin to see if it can improve fluid buildup (ascites) in people with cirrhosis. It may help reduce symptoms related to fluid retention, but you must meet specific safety and stability requirements.
This trial tests if giving albumin, a protein in the blood, can improve outcomes for patients with cirrhosis who have a specific type of bleeding from enlarged veins in the esophagus or stomach.
This trial compares two water pills (bumetanide and furosemide) in people with liver cirrhosis who need treatment for swelling from fluid buildup. It aims to see which medicine works better and is safer when started right after coming to the hospital.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.
This Phase 2 trial tests whether high-dose albumin can reduce “refractory ascites,” which is fluid buildup in the belly that doesn’t improve with the highest tolerated water pills (diuretics). If you have liver cirrhosis and need frequent drainage, this study may offer a new treatment option.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.